SCHEMBL14954371

SCHEMBL14954371

Cc1cccc2ccccc12.[Os]

nearest known ligand 0.94

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CYP2A6 P11509 8/20 0.94
▸ ALDH1A1 P00352 5/20 0.94
▸ CYP1A2 P05177 9/20 0.63
▸ HSD17B10 Q99714 5/20 0.61
▸ HPGD P15428 4/20 0.61
▸ TSHR P16473 6/20 0.54
▸ TDP1 Q9NUW8 2/20 0.50
▸ ACHE P22303 1/20 0.47
▸ CYP3A4 P08684 4/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ KEAP1 Q14145 1/20 0.46
▸ HPRT1 P00492 1/20 0.46
▸ CYP2C19 P33261 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ CASP1 P29466 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ CASP7 P55210 1/20 0.43
▸ ATM Q13315 1/20 0.43
▸ HIF1A Q16665 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL14954038 0.97 CYP2A6 (0.90) CYP2A6ALDH1A1CYP1A2HSD17B10HPGD
Fluoride SCHEMBL14954016 0.97 CYP2A6 (0.90) CYP2A6ALDH1A1CYP1A2HSD17B10HPGD
Iodide SCHEMBL14954176 0.97 CYP2A6 (0.90) CYP2A6ALDH1A1CYP1A2HSD17B10HPGD
Bromide SCHEMBL14954198 0.97 CYP2A6 (0.90) CYP2A6ALDH1A1CYP1A2HSD17B10HPGD
SCHEMBL10684163 0.97 CYP2A6 (1.00) CYP2A6ALDH1A1CYP1A2HSD17B10HPGD
SCHEMBL3075 0.97 CYP2A6 (1.00) CYP2A6ALDH1A1CYP1A2HSD17B10HPGD
SCHEMBL7517852 0.97 CYP2A6 (1.00) CYP2A6ALDH1A1CYP1A2HSD17B10HPGD
SCHEMBL29903166 0.97 CYP2A6 (1.00) CYP2A6ALDH1A1CYP1A2HSD17B10HPGD
Methane SCHEMBL16097338 0.94 CYP2A6 (0.94) CYP2A6ALDH1A1CYP1A2HSD17B10HPGD
Ammonia Solution, Strong SCHEMBL21796071 0.94 CYP2A6 (0.94) CYP2A6ALDH1A1CYP1A2HSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722912-B2 Metal complex compound and process for producing amides utilizing the metal complex compound NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY (JP) 2014-05-13 — — US disclosed
US-20130131366-A1 Metal Complex Compound and Process for Producing Amides Utilizing the Metal Complex Compound NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY (JP) 2013-05-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130131366-A1 Metal Complex Compound and Process for Producing Amides Utilizing the Metal Complex Compound AP2M1, ASH2L, AP2A1 CYP2A6 427/4885ALDH1A1 1173/4885CYP1A2 390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback